Alvotech announced a long-term agreement with a strategic partner to further enhance access to Adalimumab-ryvk in the U.S.

This company already launched India’s first private rocket. Now it’s preparing to send India’s first privately launched ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced an exclusive licensing agreement with Bioprojet to develop, ...

The majority of adult women in the US suffer urinary incontinence (UI), with the most common form of UI being Stress Urinary ...

TerraSafe continues to grow its IP portfolio to commercialize sustainable packaging solutionsNEW YORK, April 23, 2024 (GLOBE ...

InflaRx GmbH (Germany) and InflaRx Pharmaceuticals Inc. (USA) are wholly owned subsidiaries of InflaRx N.V. (together, InflaRx).

W, Mao Yiannian, said MEITUAN-W's drone service d... MEITUAN-W (03690.HK) +8.000 (+7.952%) Short selling $2.08B; Ratio 29.037 ...

Sandia National Laboratories is not just science. It’s business, too. It’s business that has an important role in the ...

Calorify kit now retails for $795 (and $995 for a Pro kit with additional metrics for athletes), “and we have a roadmap to ...

Volar Aerospace Limited (Volar), a green air mobility company based in HK, has signed a Memorandum of Understanding (MoU) ...

RAAAM Memory Technologies, a start-up company that invented a groundbreaking solution to implement on-chip memory, announced ...

(RTTNews) - Tuesday, Qualigen Therapeutics, Inc. (QLGN) announced a co-development agreement with Marizyme, Inc. to advance the commercialization of Marizyme's product, DuraGraft. DuraGraft, which ...